Aldeyra Therapeutics (ALDX) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Aldeyra Therapeutics (ALDX) is Neutral.

The composite score behind that read is -0.21, weighing +0.04 of bullish evidence against -0.38 bearish.

Aldeyra Therapeutics last closed at $0.92, -3.16% on the session.

Against the IVW growth benchmark the position is -3.96% over the forecast window.

The read is built from 15 underlying insights — 3 bullish and 12 bearish.

Agreement across those insights is 80%.

20 graded predictions for ALDX so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Aldeyra Therapeutics in the 17th percentile on return on equity, where 100 is best.

Aldeyra Therapeutics is classified under Health Care / Biotechnology, with a market capitalisation of $57.17M.

StockMap tracks Aldeyra Therapeutics as the 306th largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite Aldeyra Therapeutics ranks 317th of 381 in the group, against a group median of -0.08.